Long-term follow-up of HIV-infected patients
A Long-term Follow-up Study for HIV-infected Individuals Who Have Participated in HIV-NAT Study Protocols
This study looks at how well different HIV treatments work and their long-term effects on the health and quality of life of people living with HIV.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The HIV Netherlands Australia Thailand Research Collaboration Academic / other |
| Locations | 1 site (Bangkok) |
| Trial ID | NCT00411983 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and evaluate long-term clinical outcomes of HIV-infected participants who were previously enrolled in HIV-NAT trials. It focuses on understanding the long-term safety and effectiveness of various antiretroviral therapies, assessing factors such as CD4 cell counts and HIV viral load as predictors of disease progression. The study will also investigate the incidence of metabolic complications, resistance profiles, and the overall quality of life among participants. By gathering extensive data over time, the study seeks to provide insights into the chronic management of HIV infection.
Who should consider this trial
Good fit: Ideal candidates include HIV-infected individuals, both children and adults, who have previously participated in HIV-NAT studies or are currently enrolled in HIV-NAT trials.
Not a fit: Patients who are unable to provide written consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of long-term HIV management and improve treatment strategies for patients.
How similar studies have performed: Other studies focusing on long-term outcomes in HIV management have shown promise, indicating that this approach is both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * HIV infected patients( children and adults) previously participated HIV-NAT studies * HIV infected patients( children and adults) currently participate in HIV-NAT trials * Able to provide written consent Exclusion Criteria: * Unable to provide written consent
Where this trial is running
Bangkok
- HIV-NAT, Thai Red Cross AIDS Research Center — Bangkok, Thailand (Recruiting)
Study contacts
- Principal investigator: Praphan Phanuphak, MD, PhD — HIV-NAT, Thai Red Cross AIDS Research Center
- Study coordinator: Anchalee Avihingsanon, MD, PhD
- Email: anchalee.a@hivnat.org
- Phone: 66 2 2557334-5
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.